The purpose of this study is to determine the effectiveness of Adacel against pertussis disease in infants \< 2 months when administered during pregnancy following the current Advisory Committee on Immunization Practices (ACIP) recommendations, i.e., from 27 to 36 weeks of gestation, and 14 days or more before delivery.
The original study included cases recorded from 01 January 2011 through 31 December 2014, based on retrospective case-control methodology.
Study Type
OBSERVATIONAL
Enrollment
462
Not applicable / dataset analysis
Sanofi Pasteur
Lyon, France
Number of pertussis cases in infants less than 2 months and matched controls
Vaccine effectiveness at preventing pertussis in infants less than 2 months of age was estimated using conditional logistic regression.
Time frame: During the data collection period (from 01 January 2011 to 31 December 2014)
Number of pertussis cases requiring hospitalization in infants less than 2 months and matched controls
Vaccine effectiveness at preventing pertussis requiring hospitalization was estimated using conditional logistic regression
Time frame: During the data collection period (from 01 January 2011 to 31 December 2014)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.